A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies

BACKGROUND: Vaccine-associated anaphylaxis is a rare event (1.34 events/million doses; 0.00017% occurrence over 26 years). Several reports of allergic reactions concerning for anaphylaxis have been reported early into the Pfizer-BioNTech and Moderna coronavirus disease 2019 (COVID-19) vaccine campai...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Allergy Clin Immunol Pract
Prif Awduron: Shaker, Marcus, Abrams, Elissa M., Greenhawt, Matthew
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Academy of Allergy, Asthma & Immunology 2021
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7942189/
https://ncbi.nlm.nih.gov/pubmed/33711496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaip.2021.02.054
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg